Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis.
Saved in:
| Title: | Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis. |
|---|---|
| Authors: | Baldin VP; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States., Harding CL; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States., Quach D; Linnaeus Bioscience, Inc., San Diego, USA., Sugie J; Linnaeus Bioscience, Inc., San Diego, USA., Pogliano J; Linnaeus Bioscience, Inc., San Diego, USA., Parish T; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, United States.; Department of Pediatrics, University of Washington School of Medicine, Seattle, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Jul 01. Date of Electronic Publication: 2025 Jul 01. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
